“…Regulatory RNA can modify several immune defense signaling pathways for numerous purposes: (1) manipulating the signaling pathway of Toll-like receptors of the innate immune system for detection of pathogen-associated molecular patterns (PAMPs) [11], (2) manipulating expression of RIG-1-like receptors that normally detect PAMPs [12], (3) manipulating inflammasome priming and activation to block detection of cellular pathogens [9,13,14], (4) reducing cytokines (tumor-necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-12, IL-23) and chemokines (IL-8, CCL5, CXCL11) [4,12,[15][16][17], (5) manipulating expression of cytokine receptors [9], (6) manipulating expression of chemokine receptors to impair signaling [18], (7) impairing interleukin-1β secretion [4,13], (8) manipulating antigen processing and presentation to T-cells [19], (9) impairing NK-cell and T-cell attraction by MHC class I-related chain B (MICB) [20,21] (10) manipulating transcription factor NF-κB signaling to control gene transcription, inflammation and apoptosis [4,22], (11) regulating C-type lectin receptors (e.g., the glycan receptors for pathogens expressing mannose, fucose, β-1,3-glucan) to control major immune cell functions (e.g., inducing T H 1, T H 2 and T H 17 cell differentiation) [18], (12) manipulating cells by blocking the innate immune system Janus kinase (JAK)/signal transducer and activators of transcription (STAT) pathway [4,7,23], (13) manipulating cytokine signaling through the innate immune system mitogen-activated protein kinase (MAPK) pathways [24], (14) impairing synthesis of cellular cytosolic stimulator of interferon genes (STING) protein, which is involved in detecting cytosolic DNA viruses and other intracellular pathogen infections and inducing type I interferon production [25] and (15) delaying apoptot...…”